Skip to main content

Advertisement

Table 1 Anthropometric and clinical characteristics of patients with juvenile idiopathic arthritis and control participants a

From: Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis

  Patients with JIA(n=31) Control participants(n=84) P-value
Males/females (n) 12/19 36/48 0.692
Age (yr) 25.1 ± 6.1 23.8 ± 4.5 0.405
Height (cm) 170.5 ± 9.8 173.3 ± 9.3 0.145
Weight (kg) 68.0 ± 12.5 69.2 ± 12.5 0.884
BMI (kg/m2) 23.4 ± 3.9 22.9 ± 3.0 0.435
Vertebral fractures (n) 5 0 <0.001
Nonvertebral fractures (n) 6 0 <0.001
Family hip fracture history (n) 0 0  
Smoking (n) 7 13 0.372
Alcohol abuse (n) 0 0  
Glucocorticoids (n) 12 0 <0.001
Menarche (yr) 13.1 ± 1.2 12.9 ± 1.1 0.994
Contraception in females (n) 11 23 0.462
25(OH)D (nmol/L) 54.3 2.4 0.029
(20.2 to 168.7) (30.7 to 64.9)
PTH (pmol/L) 4.8 5.9 0.004
(1.3 to 8.8) (4.7 to 7.6)
Oestradiol (pmol/L) 98.7 103.2 0.438
(18.4 to 541.1) (56.4 to 260.3)
  1. aDisplayed are numbers or means ± SD and/or medians and 75% CIs. Characteristics with zero value were not statistically calculated. BMI: Body mass index; JIA: Juvenile idiopathic arthritis; 25(OH)D: 25-hydroxyvitamin D3; PTH: Parathyroid hormone.